Androgen receptor: structure, role in prostate cancer and drug discovery

MH Tan, J Li, HE Xu, K Melcher, E Yong - Acta Pharmacologica Sinica, 2015 - nature.com
Androgens and androgen receptors (AR) play a pivotal role in expression of the male
phenotype. Several diseases, such as androgen insensitivity syndrome (AIS) and prostate …

Src family kinases, adaptor proteins and the actin cytoskeleton in epithelial-to-mesenchymal transition

MA Ortiz, T Mikhailova, X Li, BA Porter, A Bah… - Cell Communication and …, 2021 - Springer
Over a century of scientific inquiry since the discovery of v-SRC but still no final judgement
on SRC function. However, a significant body of work has defined Src family kinases as key …

Androgen receptor signaling in prostate cancer

Z Culig, FR Santer - Cancer and Metastasis Reviews, 2014 - Springer
The androgen receptor (AR), ligand-induced transcription factor, is expressed in primary
prostate cancer and in metastases. AR regulates multiple cellular events, proliferation …

[HTML][HTML] Androgen receptor signaling in prostate cancer development and progression

PE Lonergan, DJ Tindall - Journal of carcinogenesis, 2011 - ncbi.nlm.nih.gov
The androgen receptor (AR) signaling axis plays a critical role in the development, function
and homeostasis of the prostate. The classical action of AR is to regulate gene …

[HTML][HTML] Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers

AI Ségaliny, M Tellez-Gabriel, MF Heymann… - Journal of bone …, 2015 - Elsevier
Bone cancers are characterised by the development of tumour cells in bone sites,
associated with a dysregulation of their environment. In the last two decades, numerous …

Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects

R Ferraldeschi, J Welti, J Luo, G Attard, JS De Bono - Oncogene, 2015 - nature.com
Androgen receptor (AR) signaling is a critical pathway for prostate cancer cells, and
androgen-deprivation therapy (ADT) remains the principal treatment for patients with locally …

Androgen receptor-dependent mechanisms mediating drug resistance in prostate cancer

M Ehsani, FO David, A Baniahmad - Cancers, 2021 - mdpi.com
Simple Summary Prostate cancer can develop under hormone treatment and chemotherapy
from a castration-sensitive towards a castration-resistant into a drug resistant-tumor. The …

Molecular and cellular mechanisms of castration resistant prostate cancer

Y Huang, X Jiang, X Liang, G Jiang - Oncology letters, 2018 - spandidos-publications.com
With increases in the mortality rate and number of patients with prostate cancer (PCa), PCa,
particularly the advanced and metastatic disease, has been the focus of a number of studies …

Natural compounds in prostate cancer prevention and treatment: mechanisms of action and molecular targets

F Fontana, M Raimondi, M Marzagalli, A Di Domizio… - Cells, 2020 - mdpi.com
Prostate cancer (PCa) represents a major cause of cancer mortality among men in
developed countries. Patients with recurrent disease initially respond to androgen …

Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression

JM Drake, NA Graham, T Stoyanova… - Proceedings of the …, 2012 - National Acad Sciences
Dominant mutations or DNA amplification of tyrosine kinases are rare among the oncogenic
alterations implicated in prostate cancer. We demonstrate that castration-resistant prostate …